The advantages of using AXL inhibitors goes further since it has been recently shown that AXL inhibitors enhance chemosensitivity for cisplatin in different cancer types, likely by reducing drug resistance (Hong et al., 2013; Tian et al., 2021). This evidence concerns the gene AXL and cancer.